Navigation Links
BioMarin Receives Positive Opinion from European Regulatory Authorities for Expanded Biologics Manufacturing Facility
Date:12/19/2011

approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase III clinical development for the treatment of MPS IVA, amifampridine phosphate (3,4-diaminopyridine phosphate), which is currently in Phase III clinical development for the treatment of LEMS in the U.S., PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU, BMN 701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase (IGF2-GAA), which is currently in Phase I/II clinical development for the treatment of Pompe disease, and BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor, which is currently in Phase I/II clinical development for the treatment of genetically-defined cancers. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking StatementThis press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the expectations of revenue and sales related to Naglazyme, Kuvan, Firdapse, and Aldurazyme; the financial performance of the BioMarin as a whole; the timing of BioMarin's clinical trials of GALNS, Firdapse, PEG-PAL, BMN-673, BMN-701 and other product candidates; the continued clinical development and commercialization of Aldurazyme, Naglazyme, Kuvan, Firdapse, and its product candidates; and actions by regulatory authorities. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: our success in the continued commercialization of Naglazyme, Kuvan, and Fir
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Highlights from BioMarins Research & Development Day
2. BioMarin Announces Buy Back of Naglazyme Royalties From Adelaide Health Authority
3. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
4. BioMarin Announces FDA Approval of Expanded Biologics Manufacturing Facility
5. BioMarin to Host a Research and Development Day on December 8th
6. BioMarin Announces Third Quarter 2011 Financial Results
7. BioMarin to Present at the UBS Global Life Sciences Conference
8. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
9. BioMarin to Present at the Baird Health Care Conference
10. BioMarin to Present at the Wedbush Life Sciences Conference
11. BioMarin Announces Second Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  Aptuit LLC announces ... Lafayette, Indiana , has enhanced its capabilities ... of small and large molecules, including biologic drugs, ... Bruker maXisPlus Q-TOF mass spectrometer. In ... CEO, Aptuit, said, "The expanded large molecule capability ...
(Date:8/21/2014)... , Aug. 21, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic cancers and women,s health, has appointed ... and Managed Markets. Ms. Bauzon has a ... expanding payer coverage for laboratory services companies. She has ... with PerkinElmer, Inc., where she held the position of ...
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
... North American Spine is pleased to announce a ... to bring back pain relief to Houston patients.  Starting ... Spine will perform the revolutionary AccuraScope™ Procedure ... trained by North American Spine are located in Dallas, ...
... CareTech Solutions, an information technology and Web ... U.S. hospitals, announced today that the Detroit Medical ... company,s document imaging solution, iDoc™, for the eight-facility ... "As the largest healthcare provider in southeast ...
Cached Medicine Technology:North American Spine Partners With University General Hospital to Bring Back Pain Relief to Houston Patients 2Detroit Medical Center Chooses CareTech Solutions' Document Imaging System 2
(Date:8/23/2014)... According to the new research report, ... Geography - Regional Trends & Forecast to 2019," ... an analysis and forecast of value individually. Along ... adhesives by applications and geography are also discussed ... tables and 26 figures spread through 234 pages ...
(Date:8/23/2014)... (PRWEB) August 23, 2014 Hundreds ... filed on behalf of individuals who were allegedly ... replacement line continue to move forward in the ... Liebhard LLP reports. According to an Order dated ... trial program that would allow the litigation’s first ...
(Date:8/23/2014)... The MPWMD Board of Directors voted on Monday, August 18th ... of water for commercial and industrial properties. This was ... Archworks, LLC in Carmel, California. , This is a ... district in the State of California has approved this technology ... this time can now be used as a sole source ...
(Date:8/23/2014)... (PRWEB) August 23, 2014 Dealing with a ... especially challenging when the addict is a child. Adolescent addiction ... for a long time, but a new helpline is now ... and their parents to find a real addiction recovery center. ... make a positive impact in the community. By calling (404) ...
(Date:8/23/2014)... Summer vacation is almost over and before we know ... shopping for school supplies and a new wardrobe might take ... students to also spend some time brushing up on bed ... thrive in heavily populated places,” said Randy Rupert, Bed Bug ... perfect settings for bed bugs to take up residence.” , ...
Breaking Medicine News(10 mins):Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community 2Health News:Expert Advice for a Bed Bug-Free School Year 2
... TUESDAY, Nov. 16 (HealthDay News) -- A rare, but ... hyperemesis gravidarum, may be hereditary, researchers say. Each ... are hospitalized due to hyperemesis gravidarum (HG), marked by ... cause weight loss, dehydration and psychological trauma. The condition, ...
... -- Bouts of heavy drinking can increase male teens, levels ... heavy drinking, a new study finds. The study included ... year from first-grade until they were 20 years old, with ... were teens, boys with moderate levels of impulsive behavior showed ...
... Colo. (Nov. 16, 2010) Three-year-old Denver resident Brianna,s favorite ... dog stand outside Home Depot. At 18 months she strapped ... chasing a soccer ball. She loved playing with her brother ... afternoon a few years ago from a cardiac arrhythmia known ...
... , DURHAM, N.C. The National Institutes of Health ... has awarded Duke University Medical Center up to $52.8 ... development, implementation and oversight of external quality assurance programs ... vaccine trials around the world. The project, ...
... -- Hospital care-related problems contribute to the deaths of ... new federal government study. One in seven patients ... and excessive bleeding from blood-thinning drugs, said researchers who ... in October 2008, USA Today reported. ...
... Amanda Gardner HealthDay Reporter , TUESDAY, Nov. 16 ... defective one, scientists were able to partially restore the heart,s ... "This is the first time gene therapy has been ... heart failure," study lead author Dr. Donna Mancini, professor of ...
Cached Medicine News:Health News:Rare, Severe Form of Morning Sickness Appears to Be Genetic 2Health News:For Teen Boys, Heavy Drinking & Impulsivity May Be Vicious Circle 2Health News:University of Colorado in pilot project to map defibrillators 2Health News:Duke to lead oversight of HIV laboratories worldwide 2Health News:Duke to lead oversight of HIV laboratories worldwide 3Health News:Hospital Care Deadly for Some, U.S. Study Finds 2Health News:Gene Therapy Shows Potential Against Heart Failure 2
... top-end opening spermit performing of plugs and allow ... for easy identification and sorting. Colored graduations are ... the pipet is calibrated "To Deliver" its total ... Comp Dim: O.D. L 8 350 ...
Corning 7077B L 215 mm volume 5.0 0.1 mL...
... 0.5mL PYREX glass pipets are ... blow-out and offer long, slender, ... go faster and easier. All ... fire polished tips for burr-free, ...
... ACMI® Invisio™ Flexible CystoNephroscope (ICN) employs an ... at the tip of the endoscope that ... Illumination of the surgical site is provided ... into the endoscope. This illumination technology eliminates ...
Medicine Products: